These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16776800)

  • 1. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
    Drinka PJ
    J Am Geriatr Soc; 2006 Jun; 54(6):1004-5. PubMed ID: 16776800
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
    Kay GG; Abou-Donia MB; Messer WS; Murphy DG; Tsao JW; Ouslander JG
    J Am Geriatr Soc; 2005 Dec; 53(12):2195-201. PubMed ID: 16398909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder.
    Wagg A; Verdejo C; Molander U
    Int J Clin Pract; 2010 Aug; 64(9):1279-86. PubMed ID: 20529135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overactive bladder syndrome in older people.
    Wagg AS; Cardozo L; Chapple C; De Ridder D; Kelleher C; Kirby M; Milsom I; Vierhout M
    BJU Int; 2007 Mar; 99(3):502-9. PubMed ID: 17407511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly.
    Kay GG; Granville LJ
    Clin Ther; 2005 Jan; 27(1):127-38; quiz 139-40. PubMed ID: 15763613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimuscarinics and cognitive function.
    De Ridder D
    Eur Urol; 2006 Aug; 50(2):211-2. PubMed ID: 16632192
    [No Abstract]   [Full Text] [Related]  

  • 7. Overactive bladder medicines and cognitive testing.
    Janos AL; Paggi ME; Tsao JW
    Int J Clin Pract; 2008 Nov; 62(11):1641-2. PubMed ID: 19143851
    [No Abstract]   [Full Text] [Related]  

  • 8. Restoring continence in frail older people living in the community: what factors influence successful treatment outcomes?
    Harari D; Igbedioh C
    Age Ageing; 2009 Mar; 38(2):228-33. PubMed ID: 19106253
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?
    Finney SM; Andersson KE; Gillespie JI; Stewart LH
    BJU Int; 2006 Sep; 98(3):503-7. PubMed ID: 16925744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How do medications used to treat urinary incontinence affect the cerebral function of the elderly?].
    Goepel M; Steinwachs KC
    Urologe A; 2007 Apr; 46(4):387-8, 390-2. PubMed ID: 17377763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Chapple C, Khullar V, Gabriel Z, Dooley JA. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 2005;48:5-26.
    Okpara-Kamanu RI
    Eur Urol; 2005 Nov; 48(5):873-4. PubMed ID: 16137823
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticholinergic drugs and CNS relevance for therapy].
    Madersbacher H
    Krankenpfl J; 2005; 43(7-10):187-8. PubMed ID: 16515260
    [No Abstract]   [Full Text] [Related]  

  • 13. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration.
    Wein AJ; Khullar V; Wang JT; Guan Z
    BJU Int; 2007 Feb; 99(2):360-3. PubMed ID: 17155987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
    Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimuscarinic drugs.
    McLoughlin C
    Prof Nurse; 2004 Sep; 20(1):50-1. PubMed ID: 15468784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticholinergics for overactive bladder: does subtype selectivity play a role?].
    Michel MC; Barendrecht MM; Oelke M
    Urologe A; 2006 Jul; 45(7):826-9. PubMed ID: 16767455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimuscarinic management of overactive bladder.
    Winder A
    Br J Community Nurs; 2005 Jul; 10(7):313-6. PubMed ID: 16010231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactive bladder pharmacotherapy: what does the future hold?
    Dmochowski RR
    BJU Int; 2007 Jun; 99 Suppl 3():13-6. PubMed ID: 17488368
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.
    Sand P; Zinner N; Newman D; Lucente V; Dmochowski R; Kelleher C; Dahl NV
    BJU Int; 2007 Apr; 99(4):836-44. PubMed ID: 17187655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.